Bladder Carcinoma Data with Clinical Risk Factors and Molecular Markers: A Cluster Analysis

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Variable</td><td align="center">Value</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Got</td><td align="center">25</td></tr><tr><td align="left">Gpt</td><td align="center">24</td></tr><tr><td align="left">Ca</td><td align="center">9.32</td></tr><tr><td align="left">P</td><td align="center">3.22</td></tr><tr><td align="left">Falc</td><td align="center">87</td></tr><tr><td align="left">h_c</td><td align="center">23</td></tr><tr><td align="left">Egfr</td><td align="center">10.05</td></tr><tr><td align="left">Ile</td><td align="center">61</td></tr><tr><td align="left">Negfr</td><td align="center">3</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Replacement values for the variables with missing values.

BioMed Research International

tab3

Table 3

Table 3: Bladder Carcinoma Data with Clinical Risk Factors and Molecular Markers: A Cluster Analysis 